Deep Note Understanding of CDMO Services in Pharma Typically, a Contract Manufacturing Organization; CMO or CDMO ensures outsourced services to pharma brands and companies in drug development, formulation, production, labelling, and packing. CDMO ensures that pharma firms focus on innovation …
That transformative shift over the last decade in the Oncology Medicines and drug manufacturing landscape has driven India. In fact, the growing complexity and surge in targeted therapies, biologics, and personalized medicines have increased the global demand for cancer treatments …
In the past few years, the world has witnessed certainty in global health—especially pre and post-pandemic situations—thus leading to a fast change in the medical revolution. The widespread mRNA Cancer Treatment with innovative development of vaccines and oncology has also …
Rapid development in the pharmaceutical landscape is fueled by the growing burden of diseases such as cancer. This leads to the balance over the increased demand for innovative treatments. All such aspects in global pharmaceutical companies continue to expand their …
The phenomenal growth of the Indian pharmaceutical sector has grown over the past few decades, making the nation one of the world’s leading drug producers. The various specialties in oncology, which is the field of medical treatment, are dedicated to …
Cancer still remains a leading cause of death worldwide. In fact, it continues to rise-especially in emerging economies like India. The advanced treatments such as biologics transform oncology care with high cost, and it is still challenging for many patients …
So far, with advancements and technological developments, the Indian pharmaceutical sector has established itself as one of the global leaders in generic drug manufacturing. Apart from its various segments-oncology industry has also recorded rising demand for affordable cancer medications. And …
Precisely, the oncology CDMO-drug development market is today one of the fastest growing segments in the pharma sector. From advanced formulations that are needed in complexities and sensitivity, pharma companies are increasingly turning to specialized partners for Oncology CDMOs (Contract …
Cancer is increasing—19.3 million new diagnoses and almost 10 million fatalities were recorded worldwide in 2020, states the WHO. That figure can only increase, fueling an immediate need for innovative oncology pharmaceutical companies to develop breakthrough therapies. For many pharmaceutical …
Envision a market so profitable and rapidly expanding that even the largest oncology pharmaceutical companies have difficulty keeping pace. That’s precisely what’s transpiring in oncology. Spending on oncology drugs globally surged to $223 billion in 2023 alone—a whopping $25 billion …